Pediatric and adult osteoporosis: a contrasting mirror
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pediatric osteoporosis (PO) is a condition that is currently gaining recognition. Due to the lack of official definitions over the past few decades, the exact incidence of PO is unknown. The research does not provide a specific prevalence of PO in different world regions. However, this is expected to change with the latest 2019 guidelines proposed by the International Society of Clinical Densitometry. Although adult osteoporosis (AO) has been postulated a pediatric disease because its manifestation in adulthood is a result of the bone mass acquired during childhood, differences between PO and AO should be acknowledged. AO is defined as low bone density; however, PO is diagnosed based on existing evidence of bone fragility (vertebral fractures, pathological fractures). This is particularly relevant because unlike in adults, evidence is lacking regarding the association between low bone density and fracture risk in children. The enhanced capacity of pediatric bone for reshaping and remodeling after fracture is another difference between the two entities. This contrast has therapeutic implications because medication-free bone reconstitution is possible under certain conditions; thus, background therapy is not always recommended. In this narrative review, differences between PO and AO in definition, assessment, and medical approach were investigated.
Abstract
Pediatric osteoporosis (PO) is a condition that is currently gaining recognition. Due to the lack of official definitions over the past few decades, the exact incidence of PO is unknown. The research does not provide a specific prevalence of PO in different world regions. However, this is expected to change with the latest 2019 guidelines proposed by the International Society of Clinical Densitometry. Although adult osteoporosis (AO) has been postulated a pediatric disease because its manifestation in adulthood is a result of the bone mass acquired during childhood, differences between PO and AO should be acknowledged. AO is defined as low bone density; however, PO is diagnosed based on existing evidence of bone fragility (vertebral fractures, pathological fractures). This is particularly relevant because unlike in adults, evidence is lacking regarding the association between low bone density and fracture risk in children. The enhanced capacity of pediatric bone for reshaping and remodeling after fracture is another difference between the two entities. This contrast has therapeutic implications because medication-free bone reconstitution is possible under certain conditions; thus, background therapy is not always recommended. In this narrative review, differences between PO and AO in definition, assessment, and medical approach were investigated.
참고문헌 (51)
- Cloutier MD, "Juvenile osteoporisis : report of a case including a description of some metabolic and microradiographic studies", Pediatrics, 40, pp.649~ (1967)
- Writing Group for the ISCD Position Development Conference, "Diagnosis of osteoporosis in men, premenopausal women, and children", J Clin Densitom, 7, pp.17~ (2004)
- Shuhart CR, "Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics", J Clin Densitom, 22, pp.453~ (2019)
- Bishop N, "Fracture prediction and the definition of osteoporosis in children and adolescents : the ISCD 2013 Pediatric Official Positions", J Clin Densitom, 17, pp.275~ (2014)
- Baim S, "Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference", J Clin Densitom, 11, pp.75~ (2008)
- Vokes T, "Vertebral fracture assessment : the 2005 ISCD Official Positions", J Clin Densitom, 9, pp.37~ (2006)
- Writing Group for the ISCD Position Development Conference. Position statement : executive summary, "The Writing Group for the International Society for Clinical Densitometry(ISCD)Position Development Conference", J Clin Densitom, 7, pp.7~ (2004)
- Forestier-Zhang L, "Bone strength in children : understanding basic bone biomechanics", Arch Dis Child Educ Pract Ed, 101, pp.2~ (2016)
- Chesnut CH 3rd, "Is osteoporosis a pediatric disease? Peak bone mass attainment in the adolescent female", Public Health Rep, 104(Suppl(Suppl)), pp.50~54 (1989)
- Chan CY, "A review of knowledge, belief and practice regarding osteoporosis among adolescents and young adults", Int J Environ Res Public Health, 15, pp.1727~ (2018)
- Fleming R, "Osteoporosis prevention : pediatricians’ knowledge, attitudes, and counseling practices", Prev Med, 34, pp.411~ (2002)
- "WHO Scientific Group on the Prevent ion and Management of Osteoporosis (2000 : Geneva S. Prevention and management of osteoporosis : report of a WHO scientific group" (2003)[URL]
- Kanis JA, "The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women", Osteoporos Int, 18, pp.1033~ (2007)
- Ma J, "The time to and determinants of first fractures in boys with Duchenne muscular dystrophy", Osteoporos Int, 28, pp.597~ (2017)
- Clark EM, "The epidemiology of fractures in otherwise healthy children", Curr Osteoporos Rep, 12, pp.272~ (2014)
- Simpson DE, "Large variations occur in bone density measurements of children when using different software", Nucl Med Commun, 26, pp.483~ (2005)
- Cromer BA, "Reference values for bone mineral density in 12-to 18-yearold girls categorized by weight, race, and age", Pediatr Radiol, 34, pp.787~ (2004)
- Arabi A, "Bone mineral density by age, gender, pubertal stages, and socioeconomic status in healthy Lebanese children and adolescents", Bone, 35, pp.1169~ (2004)
- Crabtree NJ, "Amalgamated reference data for sizeadjusted bone densitometry measurements in 3598children and young adults-the ALPHABET study", J Bone Miner Res, 32, pp.172~ (2017)
- Lopez-Gonzalez D, "Reference values for bone mineral density in healthy Mexican children and adolescents", Bone, 142, pp.115734~ (2021)
- Kalkwarf HJ, "Reference ranges for bone mineral content and density by dual energy x-ray absorptiometry for young children", J Clin Endocrinol Metab, 107, pp.e3887~e3900 (2022)
- LeBoff MS, "The clinician’s guide to prevention and treatment of osteoporosis", Osteoporos Int, 33, pp.2049~ (2022)
- El Maghraoui A, "DXA scanning in clinical practice", QJM, 101, pp.605~ (2008)
- "Orthopade", 2010, 361~
- Krueger D, "DXA errors are common and reduced by use of a reporting template", J Clin Densitom, 22, pp.115~ (2019)
- Leonard MB, "Assessment of bone health in children and adolescents with cancer : promises and pitfalls of current techniques", Med Pediatr Oncol, 41, pp.198~ (2003)
- El-Gazzar A, "Mechanisms of bone fragility : from osteogenesis imperfecta to secondary osteoporosis", Int J Mol Sci, 22, pp.625~ (2021)
- Ward LM, "Part I : which child with a chronic disease needs bone health monitoring?", Curr Osteoporos Rep, 19, pp.278~ (2021)
- Galindo-Zavala R, "Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children", Pediatr Rheumatol Online J, 18, pp.20~ (2020)
- Beck JJ, "What is new in pediatric bone health", J Pediatr Orthop, 41, pp.e594~e599 (2021)
- "ACR previews updated guidelines for prevention, treatment of glucocorticoid-induced osteoporosis" (2022)[URL]
- Bachrach LK, "Bone densitometry in children and adolescents", Pediatrics, 138, pp.e20162398~ (2016)
- Tan VPS, "Influence of physical activity on bone strength in children and adolescents : a systematic review and narrative synthesis", J Bone Miner Res, 29, pp.2161~ (2014)
- Janz KF, "Objectively measured physical activity trajectories predict adolescent bone strength : Iowa Bone Development Study", Br J Sports Med, 48, pp.1032~ (2014)
- Economos CD, "Beat osteoporosis-nourish and exercise skeletons(BONES) : a group randomized controlled trial in children", BMC Pediatr, 20, pp.83~ (2020)
- Kanis JA, "European guidance for the diagnosis and management of osteoporosis in postmenopausal women", Osteoporos Int, 30, pp.3~ (2019)
- Dwan K, "Bisphosphonate therapy for osteogenesis imperfecta", Cochrane Database Syst Rev, (7), pp.CD005088~ (2014)
- Ward LM, "Glucocorticoid-induced osteoporosis : why kids are different", Front Endocrinol, 11, pp.576~ (2020)
- Tadrous M, "Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis : a network meta-analysis", Osteoporos Int, 25, pp.1225~ (2014)
- Mitsuhata C, "Management of bisphosphonate preparation-treated children in the field of pediatric dentistry", Jpn Dent Sci Rev, 58, pp.155~ (2022)
- Simm PJ, "Consensus guidelines on the use of bisphosphonate therapy in children and adolescents", J Paediatr Child Health, 54, pp.223~ (2018)
- Patlas N, "Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats", Teratology, 60, pp.68~ (1999)
- Sokal A, "Pregnancy and newborn outcomes after exposure to bisphosphonates : a case-control study", Osteoporos Int, 30, pp.221~ (2019)
- Green SB, "Effects of maternal bisphosphonate use on fetal and neonatal outcomes", Am J Health-Syst Pharm, 71, pp.2029~ (2014)
- Levy S, "Pregnancy outcome following in utero exposure to bisphosphonates", Bone, 44, pp.428~ (2009)
- Stathopoulos IP, "The use of bisphosphonates in women prior to or during pregnancy and lactation", Horm Athens Greece, 10, pp.280~ (2011)
- Losada I, "Bisphosphonates in patients with autoimmune rheumatic diseases : can they be used in women of childbearing age?", Autoimmun Rev, 9, pp.547~ (2010)
- Bone HG, "10 years of denosumab treatment in postmenopausal women with osteoporosis : results from the phase 3 randomised FREEDOM trial and open-label extension", Lancet Diabetes Endocrinol, 5, pp.513~ (2017)
- Boyce AM, "Denosumab : an emerging therapy in pediatric bone disorders", Curr Osteoporos Rep, 15, pp.283~ (2017)
- Sakka SD, "Management of primary and secondary osteoporosis in children", Ther Adv Musculoskelet Dis, 12, pp.1759720~ (2020)
- Ward LM, "Anabolic therapy for the treatment of osteoporosis in childhood", Curr Osteoporos Rep, 16, pp.269~ (2018)